Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antioxidant Therapy in Sickle Cell Disease
NCT01054768Phase 2Completed
- Sponsor
- UCSF Benioff Children's Hospital Oakland
- Start
- Aug 2009
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alpha-lipoic acid, acetyl-l-carnitine in sickle cell disease (SCD), sponsored by UCSF Benioff Children's Hospital Oakland. Started Aug 2009; status: completed.
02
Drugs
alpha-lipoic acidacetyl-l-carnitine
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT01054768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01054768.